TF and neoplasm: IHC and IF analyses of tumor sections revealed a reduction in the TF activity marker fibrin (Figure 6C) and a decreased stromal collagen distribution (Figure 6D), which are consistent with mTOR inhibitor-treated tumors (Figures 4C,D, 5A).